Expecting Growth in 2026 Families are not just receiving results - they are gaining the confidence and capability to ...
With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.
REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of OncoPrism ®-NSCLC, an ...
The past decade has delivered landmark advances in human and medical genomics that shape how we understand disease mechanisms ...
Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that the Aventa™ Lymphoma test ...
Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making testing integration feasible in cancer care and improving access to ...
Genomic medicine has the potential to impact all areas of medicine and change clinical practice. In contrast to the trial-and-error of today’s practice, genomic ...
BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing technologies, will showcase its expanded portfolio for oncology and infectious disease research at ...
As cancer care increasingly shifts toward data-driven decision-making, 4baseCare is positioning itself at the intersection of genomics, AI, and clinical practice.The Bengaluru-based precision oncology ...
Bridgewater, N.J.-based Clinical Genomics launched Colvera, a blood-based test for colorectal cancer recurrence monitoring. Here’s what you need to know. 1. Colvera is a qualitative test that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results